Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
SANUWAVE Health, Inc. (SNWV)
|
Add to portfolio |
|
|
|
| Price: |
$0.17
| | Metrics |
| OS: |
1.03
|
B
| |
|
|
| Market cap: |
$174
|
M
| |
|
|
|
Net cash:
|
$332
|
k
| |
$0.00
|
per share
|
|
EV:
|
$174
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($5.6)
|
M
| |
|
|
|
EBIT
|
($6.6)
|
M
| |
|
|
| EPS |
($0.05)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 15.5 | 11.4 | 3.6 | 1.0 | 1.9 | 0.7 | 1.4 | 1.0 |
| Revenue growth | 36.3% | 213.8% | 252.7% | -44.4% | 150.5% | -46.3% | 42.5% | 13.9% |
| Cost of goods sold | 4.3 | 5.0 | 1.2 | 0.5 | 0.7 | 0.2 | 0.6 | 0.3 |
| Gross profit | 11.2 | 6.4 | 2.5 | 0.5 | 1.2 | 0.5 | 0.8 | 0.7 |
| Gross margin | 72.1% | 56.2% | 68.0% | 47.6% | 62.5% | 67.2% | 58.9% | 70.5% |
| Sales and marketing | 7.5 | 8.6 | 5.2 | 1.6 | 0.5 | | | |
| Research and development | 0.6 | 1.1 | 1.2 | 1.2 | 1.0 | 1.3 | 1.1 | 2.2 |
| General and administrative | 12.6 | 11.7 | 13.7 | 6.4 | 6.8 | 3.0 | 2.7 | 2.7 |
| EBITA | -9.0 | -14.1 | -17.3 | -8.8 | -7.2 | -3.8 | -3.0 | -4.2 |
| EBITA margin | -57.7% | -124.2% | -476.9% | -854.9% | -388.1% | -517.8% | -218.8% | -438.2% |
| Amortization of intangibles | | | 0.7 | | | | 0.3 | 0.3 |
| EBIT | -9.0 | -14.1 | -18.0 | -8.8 | -7.2 | -3.8 | -3.3 | -4.5 |
| EBIT margin | -57.7% | -124.2% | -496.6% | -854.9% | -388.1% | -517.8% | -241.1% | -470.0% |
| Pre-tax income | -10.3 | -27.2 | -30.9 | -10.4 | -11.6 | -5.5 | -6.4 | -4.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -10.3 | -27.2 | -30.9 | -10.4 | -11.6 | -5.5 | -6.4 | -4.8 |
| Net margin | -66.3% | -239.2% | -852.7% | -1013.9% | -628.7% | -749.9% | -467.9% | -498.2% |
| |
| Diluted EPS | ($0.02) | ($0.05) | ($0.08) | ($0.05) | ($0.08) | ($0.04) | ($0.06) | ($0.08) |
| Shares outstanding (diluted) | 549.5 | 518.4 | 378.1 | 203.6 | 149.5 | 138.8 | 107.6 | 63.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|